Macrophage p38 kinase inhibition for liver regeneration

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

(2018) Scott L. Friedman et al.   HEPATOLOGY

Deficiency of p38α in macrophage ameliorates d -galactosamine/TNF-α-induced acute liver injury in mice

(2017) Jiao Liu et al.   FEBS Journal

Tissue-Specific Regulation of p38α-Mediated Inflammation in Con A–Induced Acute Liver Damage

(2015) Young Jun Kang et al.   JOURNAL OF IMMUNOLOGY

Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+macrophage infiltration in mice

(2014) Christer Baeck et al.   HEPATOLOGY

Macrophage Deletion of p38  Partially Impairs Lipopolysaccharide-Induced Cellular Activation

(2014) Y. J. Kang et al.   JOURNAL OF IMMUNOLOGY

A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration

(2013) Torsten Wuestefeld et al.   CELL

Macrophage plasticity and polarization in liver homeostasis and pathology

(2013) Antonio Sica et al.   HEPATOLOGY

Phosphorylation of Atg5 by the Gadd45β–MEKK4-p38 pathway inhibits autophagy

(2012) E Keil et al.   CELL DEATH AND DIFFERENTIATION

Mechanisms and functions of p38 MAPK signalling

(2010) Ana Cuadrado et al.   BIOCHEMICAL JOURNAL

The as-yet unfulfilled promise of p38 MAPK inhibitors

(2009) Susan E. Sweeney   Nature Reviews Rheumatology